Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abbott, Astellas Collaborate on CMV Vax Trial | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Abbott, Astellas Collaborate on CMV Vax Trial

Abbott’s RealTime CMV assay to monitor patients

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott and Astellas Pharma have entered an agreement to collaborate on a Phase III trial for TransVax (ASP0113), an investigational vaccine licensed from Vical, Inc. for preventing cytomegalovirus (CMV) reactivation in transplant patients. Abbott’s RealTime CMV assay will be used to monitor patients for CMV viral load to assess the vaccine’s efficacy.
 
“Our agreement with Astellas gives us an opportunity to collaborate with another leader in the healthcare industry to better monitor patients to ensure proper treatment,” said John Coulter, head of Abbott’s molecular diagnostics business. “Abbott’s investigational CMV test will be used as an important aid in assessing the efficacy of this promising vaccine which could significantly improve the overall outcome of transplant procedures.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics